P
Peyman Rezaie
Researcher at Mashhad University of Medical Sciences
Publications - 33
Citations - 1054
Peyman Rezaie is an academic researcher from Mashhad University of Medical Sciences. The author has contributed to research in topics: Diabetes mellitus & Vitamin D and neurology. The author has an hindex of 14, co-authored 32 publications receiving 733 citations. Previous affiliations of Peyman Rezaie include Chinese Academy of Sciences.
Papers
More filters
Journal ArticleDOI
Gut microbiome and metabolic syndrome
TL;DR: Modification of gut microbiota via prebiotics, probiotics or other dietary interventions has provided evidence to support a possible beneficial effect of interventions targeting gut microbiota modulation to treat components or complications of metabolic syndrome.
Journal ArticleDOI
Effect of Sodium-Glucose Cotransport-2 Inhibitors on Blood Pressure in People With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 43 Randomized Control Trials With 22 528 Patients.
TL;DR: Treatment with SGLT2 glucose cotransporter inhibitors therefore has beneficial off‐target effects on BP in patients with type 2 diabetes mellitus and may also be of value in improving other cardiometabolic parameters including lipid profile and body weight in addition to their expected effects on glycemic control.
Journal ArticleDOI
Impact of Probiotic Administration on Serum C-Reactive Protein Concentrations: Systematic Review and Meta-Analysis of Randomized Control Trials.
TL;DR: It is suggested that probiotic administration may significantly reduce serum CRP while having no significant effect on serum IL10 and TNF-α, and these findings were robust in sensitivity analyses.
Journal ArticleDOI
Treatment with GLP1 receptor agonists reduce serum CRP concentrations in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials
TL;DR: This meta-analysis suggests that GLP-1 RAs therapy causes a significant reduction in CRP, and was associated with the duration of treatment.
Journal ArticleDOI
The effect of Ramadan fasting on cardiometabolic risk factors and anthropometrics parameters: A systematic review.
TL;DR: The incidence of acute cardiac illness during Ramadan fasting was similar when compared to non-fasting days, and the lipid profile of diabetic patients deteriorated significantlyDuring Ramadan fasting, Ramadan fasting lowers body weight, body fat percentage and BMI, however, the relationship between weight reduction and loss of body fat is not studied.